IDH2 and diffuse astrocytoma: Furthermore, if an IDH-mutant diffuse astrocytoma has a homozygous deletion of CDKN2A/B, it is classified as a CNS WHO grade 4 neoplasm, even though histologic signs of malignancy such as necrosis and microvascular proliferation are lacking (39, 45, 46).